Clinical Trial Update: Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether administering hyoscine N-butylbromide during colonoscopy increases the adenoma detection rate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• Hyoscine-n-butylbromide (hyoscine butylbromide)

Snippet

Sponsor: Valduce Hospital | Conditions: Colonic Adenomas | Phase 4 | Status: UNKNOWN